Skip to main content
. 2020 Nov 30;8:612950. doi: 10.3389/fbioe.2020.612950

FIGURE 3.

FIGURE 3

The ROS-responsive scaffold loaded with GEM and checkpoint inhibitor for chemoimmunotherapy. (A) ROS-degradable hydrogel scaffolds can achieve the co-delivery of GEM and aPDL1 into the tumor microenvironment for combination therapy. (B) The tumor growth curves of all groups. (C) The conditions of CD4+ and CD8+ T cell infiltration. Scale bar: 100 μm. (D) The numbers and ratios of immune cells in tumors under multiple treatments. Reproduced with permission from Wang C. et al. (2018).